Fabio
5.2 KiB
5.2 KiB
type, title, description, jurisdiction, legislature, session, identifier, citation, classification, subjects, status, primary_sponsors, version_count, action_count, vote_count, first_action, last_action, source, source_identifier, source_url, source_hash, vintage, source_snapshot, retrieved_at, confidence, tags
| type | title | description | jurisdiction | legislature | session | identifier | citation | classification | subjects | status | primary_sponsors | version_count | action_count | vote_count | first_action | last_action | source | source_identifier | source_url | source_hash | vintage | source_snapshot | retrieved_at | confidence | tags | |||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bill | Opioid antagonists; dispensing and administration by person acting on behalf of an organization. | Opioid antagonists; dispensing and administration by person acting on behalf of an organization. Permits persons acting on behalf of an organization that provides services to individuals at risk of experiencing an opioid overdose or training in the administration of naloxone or other opioid antagonists to dispense other opioid antagonists. The bill also allows persons to whom other opioid antagonists are dispensed to possess and administer such opioid antagonists. Under current law, persons acting on behalf of such organizations may only dispense naloxone. This bill is identical to SB 1035. | us/states/va | Virginia General Assembly | 2025 | HB 1637 | Virginia HB 1637 (2025) |
|
enacted |
|
3 | 26 | 6 | 2025-01-03 | 2025-03-24 | openstates | ocd-bill/0c12a815-1b01-4d30-ad67-541a9ce115ae | https://lis.virginia.gov/bill-details/20251/HB1637 | e78971a05eb5bbaf7efd44289cd7a2b8bd3396bafc69793b1f4d9add5b907844 | 2026-07-01 | https://data.openstates.org/daily/2026-07-01/public.pgdump | 2026-07-06 | reported |
|
Virginia HB 1637 (2025) — Opioid antagonists; dispensing and administration by person acting on behalf of an organization.
Opioid antagonists; dispensing and administration by person acting on behalf of an organization. Permits persons acting on behalf of an organization that provides services to individuals at risk of experiencing an opioid overdose or training in the administration of naloxone or other opioid antagonists to dispense other opioid antagonists. The bill also allows persons to whom other opioid antagonists are dispensed to possess and administer such opioid antagonists. Under current law, persons acting on behalf of such organizations may only dispense naloxone. This bill is identical to SB 1035.
Version chain
The bill's text revisions, in order — the diff chain from filing to enrollment.
Votes
- Subcommittee recommends reporting (7-Y 1-N) — 7–1 (pass) · lower
- Passed Senate (39-Y 0-N) — 39–0 (pass) · upper
- Read third time and passed House (93-Y 4-N) — 93–4 (pass) · lower
- Constitutional reading dispensed (on 2nd reading) (38-Y 0-N) — 38–0 (pass) · upper
- Reported from Education and Health (14-Y 0-N) — 14–0 (pass) · upper
- Reported from Health and Human Services (21-Y 1-N) — 21–1 (pass) · lower
Sponsors
- Patrick A. Hope — primary (person)
Timeline
The legislative action history — every referral, reading, and vote.
- 2025-01-03 Prefiled and ordered printed; Offered 01-08-2025 25101183D
filing, introduction - 2025-01-03 Referred to Committee on Health and Human Services
referral-committee - 2025-01-14 Fiscal Impact Statement from Department of Planning and Budget (HB1637)
- 2025-01-14 Assigned sub: Health
referral-committee - 2025-01-21 Subcommittee recommends reporting (7-Y 1-N)
- 2025-01-23 Reported from Health and Human Services (21-Y 1-N)
committee-passage - 2025-01-27 Read first time
reading-1 - 2025-01-28 Read second time and engrossed
reading-2 - 2025-01-29 Read third time and passed House (93-Y 4-N)
passage, reading-3 - 2025-01-30 Constitutional reading dispensed (on 1st reading)
- 2025-01-30 Referred to Committee on Education and Health
referral-committee - 2025-02-06 Reported from Education and Health (14-Y 0-N)
committee-passage - 2025-02-07 Rules suspended
- 2025-02-07 Constitutional reading dispensed (on 2nd reading) (38-Y 0-N)
- 2025-02-07 Passed by for the day
- 2025-02-10 Read third time
reading-3 - 2025-02-10 Passed Senate (39-Y 0-N)
passage - 2025-02-12 Enrolled
enrolled - 2025-02-12 Bill text as passed House and Senate (HB1637ER)
passage - 2025-02-12 Signed by Speaker
passage - 2025-02-14 Fiscal Impact Statement from Department of Planning and Budget (HB1637)
- 2025-02-15 Signed by President
passage - 2025-02-18 Enrolled Bill communicated to Governor on February 18, 2025
enrolled, executive-receipt - 2025-02-18 Governor's Action Deadline 11:59 p.m., March 24, 2025
executive-receipt - 2025-03-24 Approved by Governor-Chapter 370 (Effective 07/01/25)
executive-signature - 2025-03-24 Acts of Assembly Chapter text (CHAP0370)
Source
OpenStates / OpenCivicData bulk snapshot 2026-07-01; origin ocd-bill/0c12a815-1b01-4d30-ad67-541a9ce115ae. Confidence: reported (aggregated from official Virginia legislature records).